Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo

Schelch, K; Emminger, D; Zitta, B; Johnson, TG; Kopatz, V; Eder, S; Ries, A; Stefanelli, A; Heffeter, P; Hoda, MA; Hoetzenecker, K; Dome, B; Berger, W; Reid, G; Grusch, M

Grusch, M (通讯作者),Med Univ Vienna, Ctr Canc Res, Comprehens Canc Ctr, Borschkegasse 8a, A-1090 Vienna, Austria.

CANCER LETTERS, 2023; 574 ():

Abstract

Pleural mesothelioma (PM) is characterized by poor prognosis and limited therapeutic options. Y-box-binding protein 1 (YB-1) was shown to drive growth......

Full Text Link